RPC Pharma Ltd → Akari Therapeutics Plc AKTX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

3 transactions

0 buys · 0 sales · 3 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 1.00

16,430 shares short · -8.7% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-07	Patel Samir Rashmikant	director, 10%+ owner	Option exercise	1,209	$8.00	$10K
2026-07-07	Patel Samir Rashmikant	director, 10%+ owner	Option exercise	15,466	$0.00	$6
2026-07-07	Patel Samir Rashmikant	director, 10%+ owner	Option exercise	5,799	$0.00	$2

Other 13D/G Filings on Akari Therapeutics Plc

Filed	Form	Filer	Stake	Shares
2026-06-08	SCHEDULE 13G	MMCAP International Inc. SPC	—	—	view →
2025-02-14	SCHEDULE	Prudo-Chlebosz Raymond	9.30%	4,926,600,800	view →
2024-01-04	SC	RPC Pharma Ltd	—	—	view →
2022-01-14	SC	RPC Pharma Ltd	—	—	view →
2020-03-30	SC	RPC Pharma Ltd	—	—	view →

Other Filings by RPC Pharma Ltd

Filed	Form	Issuer	Stake	Shares
2024-01-04	SC	Akari Therapeutics Plc AKTX	—	—	view →
2022-01-14	SC	Akari Therapeutics Plc AKTX	—	—	view →
2020-03-30	SC	Akari Therapeutics Plc AKTX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →